Key facts
- This page summarizes Quentin S. Blackford's Form 4 filing for Axogen, Inc. (AXGN).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Apr 2022, 16:55.
Quentin S. Blackford - 30 Mar 2022 Form 4 Insider Report for Axogen, Inc. (AXGN)
- Reporting relationship
- Director
- Issuer ticker
- AXGN
- Reported as of
- 30 Mar 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Apr 2022, 16:55:16 UTC
- Prior SEC filing
- 07 Oct 2021
- Next SEC filing
- 17 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Quentin Blackford
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Quentin S. Blackford filed Form 4 for Axogen, Inc. (AXGN) on 01 Apr 2022.
Change
- Previous filing in this sequence was filed on 07 Oct 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AXGN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +3,036
- Change %
- +12%
- Price
- $0.000000
- Shares after
- 27,335
- Date
- 30 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AXGN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -3,036
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 30 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,036
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Quentin S. Blackford is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
This reflects the number of restricted stock units that became vested as of March 30, 2022.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
Footnote F3
Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units. This grant was accelerated by Axogen's Board of Directors to vest upon departure.